Your contact person
Manager PR & Communications Jan Phillip Denkers
Evotec & Takeda: strategic RNA alliance
Evotec SE today announced that the Company has entered into a multi-RNA target alliance with Takeda Pharmaceutical Company Limited (“Takeda”) with the goal to discover ...
Read more …
Indivumed Announces Expansion
Indivumed GmbH (“Indivumed”) announced today the founding of Ix Therapeutics GmbH (“Ix Therapeutics”), a joint venture with Xlife Sciences AG (“Xlife Sciences”), which marks Indivumed’s ...
Read more …
Testing power
Detecting traces of SARS-CoV-2 by PCR or antibody test has become the linchpin in the fight against the coronavirus pandemic. The diagnostics specialists from the ...
Read more …
Successful financing round worth millions for UVENTIONS
UVENTIONS has successfully closed its latest financing round worth millions. The Hamburg-based start-up, which was founded in October 2019, has been able to convince further ...
Read more …
Fraunhofer MEVIS among Winners of InnoHealth USA 2021
Fraunhofer MEVIS is among the winning teams of the call for Ideas & Innovation of the InnoHealth USA 2021 campaign. ...
Read more …
Evotec & Medical Center Hamburg-Eppendorf Enter Partnership
Evotec SE today announced that the Company has entered into a multi-year partnership with the Medical Center Hamburg-Eppendorf (“UKE”) for the development of a highly ...
Read more …
Cord Dohrmann Appointed to Council of Science & Humanities
Evotec today announced that Dr Cord Dohrmann has been appointed to the German Council of Science and Humanities (German: “Wissenschaftsrat”) for a term of three ...
Read more …
1.6 million EUR: osteolabs closes second financing round
osteolabs GmbH today announces the successful conclusion of a second financing round in the amount of approximately EUR 1.6 million. The funds were provided by ...
Read more …
Transport patients with infectious diseases
How can healthcare professionals safely transport people with infectious diseases such as COVID-19 or highly pathogenic pathogens such as Ebola? What do you have to ...
Read more …
Development partnership focused on oncology target
Evotec SE today announced a new multi-year drug development partnership with Rappta Therapeutics, a Finland-based biopharmaceutical company, focused on an innovative oncology target. ...
Read more …
synthetic mini-antibody to combat COVID-19
By screening hundreds of synthetic mini-antibodies called sybodies, a group of scientists has identified one that might stop SARS-CoV-2 from infecting human cells ...
Read more …
€ 105. M for DESY Innovation Factory
Science as a driver for innovation: DESY is building a technology and start-up centre in the heart of the future Science City Hamburg Bahrenfeld site. ...
Read more …